Shares of Richtech Robotics (RR) slid 9.8% to $2.93 on May 29, erasing gains from a sharp rally earlier in the week, as investors digested a one-two punch of regulatory trouble and unresolved legal risk that clouds the small-cap robotics company's near-term outlook. Richtech Robotics Sinks 10% as a Late Filing and a Fraud Lawsuit Raise a Blunt Question: Can This $5-Million-Revenue Company Justify a $700 Million Valuation?
Shares slumped 9.8% to $2.93 on May 29, reversing a multi-day rally, as investors confronted two unresolved threats that together paint a picture of a company struggling with basic credibility.
A Missed Deadline Puts the Nasdaq Listing at Risk. Richtech disclosed on May 28 that Nasdaq notified the company it is not in compliance with listing rules because it failed to file its quarterly financial report (10-Q) for the period ended March 31, 2026.
Nasdaq gave Richtech 60 days — until July 21 — to submit a plan to get back into compliance.
If Nasdaq accepts that plan, the company could get until November 16 to actually file, but there is no guarantee.
Recent filings show an auditor change and previously identified material weakness in internal controls, increasing focus on financial reporting quality. For a company with a roughly $729 million market cap, the inability to produce a quarterly report on time is an alarming governance signal.
The Microsoft "Partnership" That Wasn't Still Haunts the Stock. A securities class action was filed after Hunterbrook Media reported in January 2026 that Microsoft denied a commercial partnership with Richtech, sending shares down over 20% that day.
The day before that exposé, Richtech had announced a dilutive private placement of 8.5 million shares.
The alleged "collaboration" turned out to be "participation in a free prototyping program available to Microsoft customers — not a commercial partnership." The lawsuit, alleging the company misled investors to facilitate a stock sale, remains active and unresolved.
The Numbers Expose a Massive Disconnect. Over the trailing twelve months, Richtech generated just $5.0 million in revenue while posting an operating loss of $17.9 million — a negative 355.7% operating margin.
Operating cash flow was negative $9.0 million.
Meanwhile, short interest stands at 52.2 million shares — roughly 29% of the float — and has surged 282% over the past year, a sign that professional traders are betting heavily against the stock.
Where This Leaves Shareholders. The company is burning cash at roughly $18 million a year against negligible revenue, facing possible delisting, and defending a fraud suit — all while carrying a valuation north of $700 million. The most recent analyst rating remains a Buy with a $6.00 price target, but that call now sits in stark contrast to a balance sheet that cannot even produce its filings on time. Until Richtech files its overdue report and resolves the lawsuit, the stock remains a bet on narrative over substance.